Why CLDX? Celldex Therapeutics, Inc. Analysis, Price & AI Insights | Whystock
CLDX
$32.31-0.57 (-1.73%)
Market ClosedLast close May 1
Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.